Arcadia Biosciences, Inc. — Director's Dealing 2016

Sep 12, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-09-12

Reporting Person: Plavan Matthew T (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-12	Stock Option (right to buy)	$2.17	A	125000	Acquired	2026-09-11	Common Stock (125000)	Direct
2016-09-12	Stock Option (right to buy)	$6.00	A	150000	Acquired	2026-09-11	Common Stock (150000)	Direct
2016-09-12	Stock Option (right to buy)	$8.00	A	150000	Acquired	2026-09-11	Common Stock (150000)	Direct
2016-09-12	Stock Option (right to buy)	$12.00	A	37500	Acquired	2026-09-11	Common Stock (37500)	Direct
2016-09-12	Stock Option (right to buy)	$15.00	A	37500	Acquired	2026-09-11	Common Stock (37500)	Direct

Footnotes

F1: 25% of the total number of shares subject to the option will vest on 9/12/2017; the remaining 75% of the total number of shares subject to the option will vest in 36 equal installments, with the first installment occurring 9/30/2017, and thereafter on the last day of the month for the next 35 months.